ATAGI Update on the COVID-19 Vaccination Program

ATAGI recommends that all adults aged ≥ 75 years should receive an additional 2023 COVID-19 vaccine dose if 6 months have passed since their last dose.

ATAGI advises the following groups should consider an additional 2023 COVID-19 vaccine dose if 6 months have passed since their last dose, after discussion with their healthcare provider:

• All adults aged 65 to 74 years, and/or
• Adults aged 18 to 64 years with severe immunocompromise.
• Within the above groups, an additional 2023 COVID-19 vaccine is likely to be of most benefit for people who:
  • Have no known history of SARS-CoV-2 infection (and therefore are unlikely to have protection from hybrid immunity),
  • Have medical comorbidities that increase their risk of severe COVID-19, or disability with significant or complex health needs, or
  • Reside in a residential aged care facility.

ATAGI continues to encourage all adults who were recommended to have a COVID-19 vaccine dose in February 2023, and who have not yet had one, to receive a vaccine dose as soon as possible.